Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Carcinoma
Study results from National Taiwan University update understanding of carcinoma
September 18th, 2008
In this recently published study, investigators in Taipei, Taiwan conducted a study "To evaluate the effectiveness and toxicity of infusional cisplatin and weekly 24-hour infusion of high-dose fluorouracil plus leucovorin (P-HDFL) for the treatment of patients with stage IVB, recurrent and metastatic carcinoma of the cervix. A phase H study of P-HDFL in stage IVB, recurrent and metastatic carcinoma of cervix was initiated in January 2001." "As of March 2007, a total of 21 patients were enrolled. Of these, 16 were evaluable for response. The overall objective response rate was 25% [95% confidence interval (CI), 1.2-48.8%] with none achieving complete response. The...
Source: Women's Health Weekly (2008-09-18)
|
